Home

HENRI A TERMEER

CIK 1021038 · Chmn, President and CEO · last filed 2016-08-11

HENRI A TERMEER is a Chmn, President and CEO who has filed 75 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for APOL, was dated Aug 11, 2016. Across all open-market trades the lifetime net is −$60.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $30.5K across reported positions. 46 SEC filings were submitted jointly with ABIOMED INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$30.5K

Companies

4

Total Filings

75

Lifetime Open-Market Net

-$60.68M

Filer Profile

Reported Address
ONE KENDALL SQUARE
CAMBRIDGE, MA 02139
State of Incorporation
MA
Related Filers
ABIOMED INC — 46 joint filings, latest 2016-08-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABIOMED INC (APOL) Delisted Director 2,131,134 — — -$3.68M 40 2016-08-11
AVEO PHARMACEUTICALS, INC. (AVEO) Delisted Director 38,599 $15.00 $579.0K $667.2K 13 2016-05-31
VSTM Director 3,849 $7.93 $30.5K $552.6K 7 2015-06-16
GENZ Chmn, President and CEO 0 $38.11 $0 -$58.22M 14 2011-04-06

Recent Filings

75 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-08-11 ABIOMED INC (APOL) Delisted Mixed +1,621 $0 EDGAR
2016-08-03 ABIOMED INC (APOL) Delisted Mixed +26,134 -$2.43M EDGAR
2016-05-31 AVEO PHARMACEUTICALS, INC. (AVEO) Delisted Grant (A) — $0 EDGAR
2016-05-17 AVEO PHARMACEUTICALS, INC. (AVEO) Delisted Grant (A) +259,067 $0 EDGAR
2015-08-14 ABIOMED INC (APOL) Delisted Grant (A) +3,900 $0 EDGAR
2015-08-05 ABIOMED INC (APOL) Delisted Exer (M) +8,000 $80.5K EDGAR
2015-06-16 VSTM Grant (A) — $0 EDGAR
2015-06-01 AVEO PHARMACEUTICALS, INC. (AVEO) Delisted Grant (A) — $0 EDGAR
2015-04-06 AVEO PHARMACEUTICALS, INC. (AVEO) Delisted Grant (A) — $0 EDGAR
2015-03-19 — Disp (D) −2,500 $0
Showing 1–10 of 75
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.